This report contains market size and forecasts of Nucleic Acid-based Drugs in Global, including the following market information:
Global Nucleic Acid-based Drugs Market Size 2024-2032, ($ millions)
The global Nucleic Acid-based Drugs market is projected to reach US$ million by 2032.
We surveyed the Nucleic Acid-based Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Acid-based Drugs Market, by Type, 2024-2032 ($ millions)
Global Nucleic Acid-based Drugs Market Segment Percentages, by Type
ASO
mRNA
siRNA
miRNA
saRNA
Aptamer
Global Nucleic Acid-based Drugs Market, by Application, 2024-2032 ($ millions)
Global Nucleic Acid-based Drugs Market Segment Percentages, by Application
Genetic Disease
Cancer
Cardiovascular Diseases
Other
Global Nucleic Acid-based Drugs Market, By Region and Country, 2024-2032 ($ Millions)
Global Nucleic Acid-based Drugs Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals
